Published in Am J Pathol on September 01, 1985
Cytokeratins in normal and malignant transitional epithelium. Maintenance of expression of urothelial differentiation features in transitional cell carcinomas and bladder carcinoma cell culture lines. Am J Pathol (1988) 1.47
Characterization of a novel transplantable orthotopic rat bladder transitional cell tumour model. Br J Cancer (1999) 1.20
Choroid plexus tumors. An immunocytochemical study with particular reference to the coexpression of intermediate filament proteins. Am J Pathol (1987) 0.97
Bracken fern-induced bladder tumors in guinea pigs. A model for human neoplasia. Am J Pathol (1995) 0.96
Cross-species comparison of orthologous gene expression in human bladder cancer and carcinogen-induced rodent models. Am J Transl Res (2010) 0.95
Current animal models of bladder cancer: Awareness of translatability (Review). Exp Ther Med (2014) 0.78
Tumor establishment features of orthotopic murine bladder cancer models. Korean J Urol (2012) 0.75
Epidermolysis bullosa herpetiformis (Dowling-Meara type) exhibits ultrastructural derangement of tonofilaments and desmosomes. Arch Dermatol Res (1994) 0.75
Two new cytotoxic candidaspongiolides from an indonesian sponge. ISRN Pharm (2011) 0.75
The catalog of human cytokeratins: patterns of expression in normal epithelia, tumors and cultured cells. Cell (1982) 19.91
[Organotropic carcinogenic effects of 65 various N-nitroso- compounds on BD rats]. Z Krebsforsch (1967) 5.30
[SELECTIVE INDUCTION OF BLADDER CANCER IN RATS BY DIBUTYL- AND N-BUTYL-N-BUTANOL(4)-NITROSAMINE]. Z Krebsforsch (1964) 1.87
Monoclonal antibody to keratin filaments, specific for glandular epithelia and their tumors. Use in surgical pathology. Lab Invest (1983) 1.65
Antibodies to intermediate filament proteins in the immunohistochemical identification of human tumours: an overview. Histochem J (1983) 1.50
Use of antibodies to intermediate filaments in the characterization of human tumors. Cold Spring Harb Symp Quant Biol (1982) 1.16
Histogenesis of urinary bladder tumors induced by N-butyl-N-(4-hydroxybutyl)nitrosamine in rats. Gan (1969) 1.09
Scanning and transmission electron microscopy of changes in the urinary bladder in rats treated with N-butyl-N-(4-hydroxybutyl)nitrosoamine. Gan (1974) 1.05
Tissue culture of urinary bladder tumor induced in a rat by N-butyl-N-(-4-hydroxybutyl)nitrosamine: establishment of cell line, Nara Bladder Tumor II. J Natl Cancer Inst (1971) 1.03
Histological classification of urinary bladder cancers in rats induced by N-butyl-n-(4-hydroxybutyl)nitrosamine. Gan (1976) 1.00
Morphologic changes in rat urothelial cells during carcinogenesis: I. Histologic and cytologic changes. Cytometry (1984) 0.99
Cytokeratin expression during neoplastic progression of human transitional cell carcinomas as detected by a monoclonal and a polyclonal antibody. Lab Invest (1985) 0.99
Demonstration of keratin in human adenocarcinomas. Am J Pathol (1983) 0.98
Is renal cell (Grawitz) tumor a carcinosarcoma? Evidence from analysis of intermediate filament types. Virchows Arch B Cell Pathol Incl Mol Pathol (1983) 0.95
Effect of various factors on induction of urinary bladder tumors in animals by N-butyl-n-(4-hydroxybutyl)nitrosoamine. Gan (1973) 0.93
Urothelial dysplasia. J Urol (1982) 0.88
Localization of a Mr 52,000 keratin in basal epithelial cells of the mouse bladder and expression throughout neoplastic progression. Cancer Res (1982) 0.86
Morphology, classification and histogenesis of N-butyl-N-(4-hydroxybutyl)-nitrosamine-induced carcinomas in the urinary bladder of rats. Z Krebsforsch Klin Onkol Cancer Res Clin Oncol (1977) 0.86
Development of urinary bladder cancer in the rat. Curr Top Pathol (1979) 0.85
Flow-cytometric analysis of mixed cell populations using intermediate filament antibodies. Exp Cell Res (1984) 0.84
Comparison of bladder tumors induced in rats and mice with N-butyl-N-(4-hydroxybutyl)-nitrosoamine. Gan (1973) 0.82
Carcinoma of the urinary bladder. Am J Pathol (1979) 0.79
Flow cytometric analysis and sorting of human endometrial cells after immunocytochemical labeling for cytokeratin using a monoclonal antibody. Cytometry (1985) 0.79
Annexin V-affinity assay: a review on an apoptosis detection system based on phosphatidylserine exposure. Cytometry (1998) 5.30
Incidence and treatment of complications of bacillus Calmette-Guerin intravesical therapy in superficial bladder cancer. J Urol (1992) 4.79
DD3: a new prostate-specific gene, highly overexpressed in prostate cancer. Cancer Res (1999) 4.67
Immunocytochemical detection and mapping of a cytokeratin 18 neo-epitope exposed during early apoptosis. J Pathol (1999) 3.28
Contribution of mutations in the cytochrome P450 14alpha-demethylase (Erg11p, Cyp51p) to azole resistance in Candida albicans. Microbiology (1999) 3.19
Expression of the cellular adhesion molecule E-cadherin is reduced or absent in high-grade prostate cancer. Cancer Res (1992) 2.55
A novel assay to measure loss of plasma membrane asymmetry during apoptosis of adherent cells in culture. Cytometry (1996) 2.39
Decreased E-cadherin expression is associated with poor prognosis in patients with prostate cancer. Cancer Res (1994) 2.34
In situ hybridization as a tool to study numerical chromosome aberrations in solid bladder tumors. Histochemistry (1988) 2.26
Characterization of human c-fes/fps reveals a new transcription unit (fur) in the immediately upstream region of the proto-oncogene. Mol Biol Rep (1986) 2.16
Dynamics of the nuclear lamina as monitored by GFP-tagged A-type lamins. J Cell Sci (1999) 2.14
Automated prostate volume determination with ultrasonographic imaging. J Urol (1995) 2.13
Decreased E-cadherin immunoreactivity correlates with poor survival in patients with bladder tumors. Cancer Res (1993) 2.09
Transient expression of phosphatidylserine at cell-cell contact areas is required for myotube formation. J Cell Sci (2001) 2.03
Both emerin and lamin C depend on lamin A for localization at the nuclear envelope. J Cell Sci (2001) 2.01
Colocalization of basal and luminal cell-type cytokeratins in human prostate cancer. Cancer Res (1992) 1.98
An alternative splicing product of the lamin A/C gene lacks exon 10. J Biol Chem (1996) 1.98
The occurrence of interval cancers in the Nijmegen screening programme. Br J Cancer (1989) 1.94
Localization of the E1B proteins of adenovirus 5 in transformed cells, as revealed by interaction with monoclonal antibodies. Virology (1985) 1.94
Basal cell-specific and hyperproliferation-related keratins in human breast cancer. Am J Pathol (1991) 1.88
Adult rabbit cardiomyocytes undergo hibernation-like dedifferentiation when co-cultured with cardiac fibroblasts. Cardiovasc Res (2001) 1.85
Rapid synthesis of biotin-, digoxigenin-, trinitrophenyl-, and fluorochrome-labeled tyramides and their application for In situ hybridization using CARD amplification. J Histochem Cytochem (1998) 1.82
Smoothelin, a novel cytoskeletal protein specific for smooth muscle cells. J Cell Biol (1996) 1.73
Ki-67 detects a nuclear matrix-associated proliferation-related antigen. II. Localization in mitotic cells and association with chromosomes. J Cell Sci (1989) 1.67
Histological grade heterogeneity in multifocal prostate cancer. Biological and clinical implications. J Pathol (1996) 1.64
fur gene expression as a discriminating marker for small cell and nonsmall cell lung carcinomas. J Clin Invest (1987) 1.63
Cytokeratins in different types of human lung cancer as monitored by chain-specific monoclonal antibodies. Cancer Res (1988) 1.60
A practical clinical method for contour determination in ultrasonographic prostate images. Ultrasound Med Biol (1994) 1.60
Selective detrusor activation by electrical sacral nerve root stimulation in spinal cord injury. J Urol (1997) 1.58
Psoriasis: maintenance of an intact monolayer basal cell differentiation compartment in spite of hyperproliferation. Br J Dermatol (1985) 1.58
Factors affecting recurrence and progression in superficial bladder tumours. Eur J Cancer (1995) 1.58
Identification of the cytoskeletal proteins in lens-forming cells, a special epitheloid cell type. Exp Cell Res (1980) 1.58
TNM classification of genitourinary tumours 1987--position of the EORTC Genitourinary Group. Br J Urol (1988) 1.55
Distribution of cytokeratin polypeptides in human transitional cell carcinomas, with special emphasis on changing expression patterns during tumor progression. Am J Pathol (1990) 1.53
Detection of numerical chromosome aberrations using in situ hybridization in paraffin sections of routinely processed bladder cancers. Mod Pathol (1991) 1.53
Antibodies to intermediate filament proteins in the immunohistochemical identification of human tumours: an overview. Histochem J (1983) 1.50
The applicability of a keratin 7 monoclonal antibody in routinely Papanicolaou-stained cytologic specimens for the differential diagnosis of carcinomas. Am J Clin Pathol (1994) 1.47
Detection of basement membrane components and basal cell keratin 14 in noninvasive and invasive carcinomas of the breast. Am J Pathol (1989) 1.46
Differentiation of smooth muscle cells in human blood vessels as defined by smoothelin, a novel marker for the contractile phenotype. Arterioscler Thromb Vasc Biol (1997) 1.44
Convention on nomenclature for DNA cytometry. Committee on Nomenclature, Society for Analytical Cytology. Cancer Genet Cytogenet (1984) 1.42
Prognostic value of cadherin-associated molecules (alpha-, beta-, and gamma-catenins and p120cas) in bladder tumors. Cancer Res (1996) 1.41
Quality-of-life assessment in patients after laser prostatectomy. Br J Urol (1997) 1.41
Monoclonal antibody against human ovarian tumor-associated antigens. J Natl Cancer Inst (1986) 1.40
A- and B-type lamins are differentially expressed in normal human tissues. Histochem Cell Biol (1997) 1.40
Ki-67 detects a nuclear matrix-associated proliferation-related antigen. I. Intracellular localization during interphase. J Cell Sci (1989) 1.38
Urinary tract infections following laser prostatectomy: is there a need for antibiotic prophylaxis? Br J Urol (1996) 1.38
Prognosis and treatment of T1G3 bladder tumours. A prognostic factor analysis of 121 patients. Dutch South Eastern Bladder Cancer Study Group. Eur J Cancer (1994) 1.38
Comparison of different computer models of the neural control system of the lower urinary tract. Neurourol Urodyn (2000) 1.37
Properties of rat tracheal epithelial cells separated based on expression of cell surface alpha-galactosyl end groups. Am J Respir Cell Mol Biol (1991) 1.37
Optimal preparation of preimplantation embryo interphase nuclei for analysis by fluorescence in-situ hybridization. Hum Reprod (1994) 1.36
Upstream regions of the hamster desmin and vimentin genes regulate expression during in vitro myogenesis. EMBO J (1987) 1.36
Differential expression of keratins in the basal and luminal compartments of rat prostatic epithelium during degeneration and regeneration. Prostate (1988) 1.35
Screening errors in cervical cytologic screening. Acta Cytol (1987) 1.35
Targeting of renal cell carcinoma with iodine-131-labeled chimeric monoclonal antibody G250. J Clin Oncol (1997) 1.35
The effects of treatment of urinary incontinence in general practice. Fam Pract (1992) 1.32
Keratins 7 and 20 as diagnostic markers of carcinomas metastatic to the ovary. Hum Pathol (1995) 1.32
Increased expression of high mobility group protein I(Y) in high grade prostatic cancer determined by in situ hybridization. Cancer Res (1993) 1.29
Coexpression of keratin- and vimentin-type intermediate filaments in human metastatic carcinoma cells. Proc Natl Acad Sci U S A (1983) 1.28
Identification of intermediate cell types by keratin expression in the developing human prostate. Prostate (1998) 1.27
Nuclear A-type lamins are differentially expressed in human lung cancer subtypes. Am J Pathol (1993) 1.27
Identification of the sex of human preimplantation embryos in two hours using an improved spreading method and fluorescent in-situ hybridization (FISH) using directly labelled probes. Hum Reprod (1994) 1.24
[Recommendations in aberrant findings of cytological studies of the cervix uteri]. Ned Tijdschr Geneeskd (1987) 1.23
Ciprofloxacin distribution in prostatic tissue and fluid following oral administration. Chemotherapy (1985) 1.23
Decreased expression of E-cadherin in the progression of rat prostatic cancer. Cancer Res (1992) 1.23
Metastasectomy in renal cell carcinoma: A multicenter retrospective analysis. Eur Urol (1999) 1.22
Accuracy of urinary cytology in the diagnosis of primary and recurrent bladder cancer. Acta Cytol (1993) 1.22
Controlled trial of pelvic floor exercises in the treatment of urinary stress incontinence in general practice. Br J Gen Pract (1991) 1.22
Numerical chromosome 1, 7, 9, and 11 aberrations in bladder cancer detected by in situ hybridization. Cancer Res (1991) 1.20
The correlation between bladder outlet obstruction and lower urinary tract symptoms as measured by the international prostate symptom score. J Urol (1996) 1.19
Molecular analysis of multifocal prostate cancer lesions. J Pathol (1999) 1.19
Phase I radioimmunotherapy of metastatic renal cell carcinoma with 131I-labeled chimeric monoclonal antibody G250. Clin Cancer Res (1999) 1.19
Orchiectomy and nilutamide or placebo as treatment of metastatic prostatic cancer in a multinational double-blind randomized trial. J Urol (1993) 1.18
Identification of high mobility group protein I(Y) as potential progression marker for prostate cancer by differential hybridization analysis. Cancer Res (1991) 1.18
Relation between aberrant alpha-catenin expression and loss of E-cadherin function in prostate cancer. Int J Cancer (1997) 1.17
Distribution of cytokeratin polypeptides in epithelia of the adult human urinary tract. Histochemistry (1989) 1.17
Intermediate filament proteins in classic and variant types of small cell lung carcinoma cell lines: a biochemical and immunochemical analysis using a panel of monoclonal and polyclonal antibodies. J Cell Sci (1986) 1.17
Leukocytes in the urine after intravesical BCG treatment for superficial bladder cancer. A flow cytofluorometric analysis. Urol Res (1991) 1.17
Presence of activated lymphocytes in the urine of patients with superficial bladder cancer after intravesical immunotherapy with bacillus Calmette-Guérin. Cancer Immunol Immunother (1991) 1.16
Use of antibodies to intermediate filaments in the characterization of human tumors. Cold Spring Harb Symp Quant Biol (1982) 1.16
Immunocytochemical detection of human lung cancer heterogeneity using antibodies to epithelial, neuronal, and neuroendocrine antigens. Cancer Res (1987) 1.15
Induction of urinary interleukin-1 (IL-1), IL-2, IL-6, and tumour necrosis factor during intravesical immunotherapy with bacillus Calmette-Guérin in superficial bladder cancer. Cancer Immunol Immunother (1992) 1.15
Lenticular intermediate-sized filaments: biosynthesis and interaction with plasma membrane. Proc Natl Acad Sci U S A (1982) 1.15